Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] - 1 Nov 2024

Apurva, Nimisha, Sharma Abhay Kumar, Kumar Arun, Ahmad Ejaj, Santoshi Seneha, Saluja Sundeep Singh

Abstract excerpt

BACKGROUND: Biological behaviour of Periampullary cancers (PACS) differs from pancreatic head cancer, and analysis of molecular alteration is needed. BRAF and HER2 are keys members of the RAS/RAF and EGFR pathway, playing roles in prognostic markers and therapeutic targets. METHODS: A study on 89 PACS patients, undergoing Whipple Pancreaticoduodenectomy, PCR-RFLP, and qPCR methods used for SNP and mRNA expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Pancreatic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Receptor, ErbB-2

Share to Survival Analysis

Source

Identifiers

PMID: 39191597
DOI: 10.1016/j.pan.2024.08.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.PMID 39191597Read ↗

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An OverviewSemantic proximity Read ↗

Advances in Molecular Pathology and Treatment of Periampullary Cancers.Semantic proximity Read ↗

Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes.Semantic proximity Read ↗

BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities.Semantic proximity Read ↗

Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers.Semantic proximity Read ↗

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.Semantic proximity Read ↗

Ampullary carcinoma-A genetic perspective.Semantic proximity Read ↗

TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective cohort study.Semantic proximity Read ↗

Molecular pathways in periampullary cancer: An overviewSemantic proximity Read ↗

Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.Semantic proximity Read ↗

Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing.Semantic proximity Read ↗

KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.